Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease

Background: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators represent targeted therapies directly acting on the CFTR channel. The triple therapy Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) has been demonstrated to improve lung function and quality of life in cystic fibrosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Giallongo, Alessandro, Parisi, Giuseppe Fabio, Papale, Maria, Manti, Sara, Mulé, Enza, Aloisio, Donatella, Terlizzi, Vito, Rotolo, Novella, Leonardi, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956139/
https://www.ncbi.nlm.nih.gov/pubmed/36833376
http://dx.doi.org/10.3390/genes14020449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956139/
https://www.ncbi.nlm.nih.gov/pubmed/36833376
http://dx.doi.org/10.3390/genes14020449

Ejemplares similares